Literature DB >> 14945979

Cure of Korean vivax malaria with pamaquine and primaquine.

P L GARRISON, D D HANKEY, W G COKER, W N DONOVAN, B JASTREMSKI, G R COATNEY, A S ALVING, R JONES.   

Abstract

Entities:  

Keywords:  MALARIA/therapy; PAMAQUINE/therapeutic use; QUINOLINES

Mesh：

Substances：

Year:  1952        PMID： 14945979     DOI： 10.1001/jama.1952.72930340021010a

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  8 in total

1.  Primaquine and quinocide as curative agents against sporozoite-induced Chesson strain vivax malaria.

Authors:  G R COATNEY; M E GETZ
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

2.  Malaria in Korean veterans.

Authors:  T R HALE; G W HALPENNY
Journal:  Can Med Assoc J       Date:  1953-05       Impact factor: 8.262

Review 3.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

Review 4.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

5.  Relationships between chemical structures of 8-aminoquinolines and their capacities for radical cure of infections with Plasmodium cynomolgi in rhesus monkeys.

Authors:  L H Schmidt
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

6.  LATENT INFECTIONS WITH PLASMODIUM OVALE MALARIA.

Authors:  M J MILLER; D M MARCUS; D G CAMERON
Journal:  Can Med Assoc J       Date:  1965-06-12       Impact factor: 8.262

7.  Effects of suspended residual spraying and of imported malaria on malaria control in the USA.

Authors:  J M ANDREWS; J S GRANT; R F FRITZ
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

8.  Liver-stage fate determination in Plasmodium vivax parasites: Characterization of schizont growth and hypnozoite fating from patient isolates.

Authors:  Amélie Vantaux; Julie Péneau; Caitlin A Cooper; Dennis E Kyle; Benoit Witkowski; Steven P Maher
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.